Physician

Shaival J Kapadia, MD

According to 2025 Medicare claims, Shaival Kapadia, MD (NPI: 1609891985) practices cardiology in the Richmond, VA market, with the plurality of this provider's patient population coming from Chesterfield, VA. This provider's primary affiliated billing organization is JAMES RIVER CARDIOLOGY, LLC (NPI: 1407157647; TIN: 27-3851927) and primary practice location at 23832-2826.

Kapadia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,698 traditional Medicare patients, billed 66,752 HCPCS/CPT codes, and received $1,832,759 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 4,452 prescription claims across 849 beneficiaries totaling $1,073,894 in drug costs, led by Eliquis (Apixaban). 2018 DME data shows 76 claims. Open Payments data shows 64 records totaling $3,616. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $188,221 to $1,832,759. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,162	3,939	$188,221
2016	1,176	4,204	$188,976
2017	1,206	3,890	$187,906
2018	1,305	4,131	$206,183
2019	1,347	4,303	$224,861
2020	1,119	3,105	$152,625
2021	1,306	7,065	$636,769
2022	1,079	6,698	$496,879
2023	1,306	20,309	$784,027
2024	1,698	66,752	$1,832,759

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	676	7,060	$679,766
2016	660	6,646	$714,522
2017	687	6,522	$719,842
2018	712	5,125	$630,700
2019	615	2,970	$505,849
2020	598	2,899	$601,357
2021	427	1,555	$353,774
2022	455	1,870	$450,642
2023	620	3,139	$719,191
2024	849	4,452	$1,073,894

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	38	$2,542
2016	N/R	57	$2,504
2017	N/R	90	$3,709
2018	N/R	76	$4,965
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	570	587	$127
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,038	2,022	$82
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	348	350	$47
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	681	750	$9
J2785	Injection, regadenoson, 0.1 mg	347	1,393	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	275	13,659	$260,003
Entresto	Sacubitril/Valsartan	180	10,495	$229,914
Jardiance	Empagliflozin	109	4,977	$95,420
Xarelto	Rivaroxaban	72	3,620	$65,755
Repatha Sureclick	Evolocumab	50	2,070	$40,562

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	64	$3,616	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shaival J. Kapadia, MD?

Tedicare shows public-source Medicare data for Shaival J. Kapadia, MD (NPI 1609891985), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shaival J. Kapadia, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Shaival J. Kapadia, MD?

Shaival J. Kapadia, MD is linked to JAMES RIVER CARDIOLOGY, LLC (billing NPI 1407157647) in the available physician profile data.

Does Shaival J. Kapadia, MD have Open Payments data?

Shaival J. Kapadia, MD has 64 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.